Response to: 'Correspondence on 'Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis'' by Lee.

Akiyama, Shintaro; Hamdeh, Shadi; Micic, Dejan; Sakuraba, Atsushi

Akiyama, Shintaro; Hamdeh, Shadi; Micic, Dejan; Sakuraba, Atsushi.

Akiyama S; Inflammatory Bowel Disease Center, The University of Chicago Medicine, Chicago, Illinois, USA.
Hamdeh S; Department of Internal Medicine, Division of Gastroenterology, Hepatology and Motility, University of Kansas, Kansas City, Kansas, USA.
Micic D; Inflammatory Bowel Disease Center, The University of Chicago Medicine, Chicago, Illinois, USA.
Sakuraba A; Inflammatory Bowel Disease Center, The University of Chicago Medicine, Chicago, Illinois, USA asakurab@medicine.bsd.uchicago.edu.

Ann Rheum Dis ; 2021 Jan 27.

Article in English | MEDLINE | ID: covidwho-2248519

Keywords

COVID-19; autoimmune diseases; epidemiology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study / Prognostic study / Reviews / Systematic review/Meta Analysis Language: English Year: 2021 Document Type: Article Affiliation country: Annrheumdis-2021-219918

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google